| | Tay-Sachs Disease, Ab Variant (Gangliosidosis GM2, AB Variant; Gangliosidosis GM2, Type AB; GM2 Protein Activator Deficiency Disease)
A progressive neurodegenerative disorder that begins with muscle weakness, then progresses to startle reaction, retardation and seizures. It is characterized by the accumulation of G(M2) GANGLIOSIDE in neurons that is caused by a lack of G(M2) ACTIVATOR PROTEIN function. The AB variant designation refers to the increase of both HEXOSAMINIDASE A and HEXOSAMINIDASE B in tissues that lack of G(M2) activator protein.
 to tay-sachs disease ab www.malacards.org
|  with Tay-sachs Disease Ab www.malacards.org
|  Tay-Sachs Disease, Ab Variant www.lookfordiagnosis.com
|  Tay-Sachs AB Variant, themedicalbiochemistrypage.org
|  Tay-Sachs AB Variant, themedicalbiochemistrypage.org
|  of Tay-Sachs Disease, AB www.authoratory.com
|  seen in Tay Sachs disease: en.wikipedia.org
|  Post-infantile Tay–Sachs was en.wikipedia.org
|
Diagnosis and therapies
Wikipedia Hexosaminidase, GM2 gangliosidoses, Cellular reproduction and DNA replication: Point mutation, Tay–Sachs disease, Jewish population by cities and city areas, Jewish population by urban areas, Disease carrier, HEXA, French Canadian American, National Jewish Population Survey
More information
- Reported cases - Summary of cases reported on this disease.
- Related terms - Look for sites, images, videos, news and articles about related terms.
- SearchMedica - Professional Medical Search.
- WHO - World Health Organization.
- PubMed - A service of the National Library of Medicine and National Institutes of Health.
- MEDLINE - Literature from the National Library of Medicine.
- MeSH - Medical Subject Headings.
- DeCS - Health Sciences Descriptors.
|